Findings point to possibility of new 'anti-evolution drugs' to keep hard-to-treat pathogens from arising.
A class of drugs called angiotensin-II receptor blockers was associated with benefit for black women and white women and men.
The advance paves the way for building entirely novel, custom-designed antibodies, enzymes and other biologically active proteins.
By clustering patients based on blood levels of select biomarkers, researchers learned who is likelier to benefit from a specific therapy.
Toxin Tre1 attacks competing bacteria by a mechanism similar to the way pertussis, cholera and diphtheria toxins target people.
Brushing and toothpaste can't dispel cavity-causing bacteria, despite advertising claims going back more than 100 years.
Regenerative therapy for glaucoma is one of the National Eye Institute Audacious Goals.
In a specific area of the genome, variations were associated with a 26 percent increased risk of the sexually limiting condition.
Study involved 2,548 people; those who had highest levels of marker at outset were likelier to develop kidney problems.
Stem cell biologist Sergei Doulatov is working to improve bone marrow transplant options, understand blood diseases, and maintain healthy blood systems
